Inhibikase Therapeutics Stock (IKT)
Track Inhibikase Therapeutics stock through TheStreet Pro's latest coverage, including articles, Daily Diary mentions, TheStreet Pro portfolio activity, contributor watchlist signals, and Pro price levels.
IKT
Inhibikase Therapeutics
healthcare
At close
$1.63
▼ -0.03 (-1.81%)
Jun 5, 4:00 PM ET
After-hours
$1.61
▼ -0.02 (-1.18%)
Jun 5, 7:24 PM ET
Market Cap
$220.49M
P/E Ratio
—
1Y Return
-16.84%
EPS (TTM)
-$0.43
Read the latest TheStreet Pro articles mentioning Inhibikase Therapeutics, including market roundups, portfolio updates, trade ideas, and investing analysis.
Articles
0 articlesNo articles mentioning IKT yet.
Daily Diary Mentions
0 mentionsNo diary mentions for IKT yet.